These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8285640)
21. Changing patterns of the prevalence of different Shigella species and their antibiotic susceptibilities in Ankara, Turkey. Ceyhan M; Akan O; Kanra G; Ecevit Z; Seçmeer G; Berkman E J Diarrhoeal Dis Res; 1996 Sep; 14(3):187-9. PubMed ID: 9019012 [TBL] [Abstract][Full Text] [Related]
22. Changes in patterns of antimicrobial susceptibility and integron carriage among Shigella sonnei isolates from southwestern Korea during epidemic periods. Oh JY; Yu HS; Kim SK; Seol SY; Cho DT; Lee JC J Clin Microbiol; 2003 Jan; 41(1):421-3. PubMed ID: 12517883 [TBL] [Abstract][Full Text] [Related]
23. Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to India. De Lappe N; O'Connor J; Garvey P; McKeown P; Cormican M Emerg Infect Dis; 2015 May; 21(5):894-6. PubMed ID: 25897625 [No Abstract] [Full Text] [Related]
24. Detection of CTX-M-14 extended-spectrum beta-lactamase in Shigella sonnei isolates from China. Xiong Z; Li T; Xu Y; Li J J Infect; 2007 Nov; 55(5):e125-8. PubMed ID: 17767959 [TBL] [Abstract][Full Text] [Related]
25. Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins. Morrissey I; George J Antimicrob Agents Chemother; 1999 Nov; 43(11):2579-85. PubMed ID: 10543732 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones. Hirose K; Terajima J; Izumiya H; Tamura K; Arakawa E; Takai N; Watanabe H Antimicrob Agents Chemother; 2005 Mar; 49(3):1203-5. PubMed ID: 15728928 [TBL] [Abstract][Full Text] [Related]
27. [Reliabilty of the antibiogram and plasmid profile in detection of epidemic strains of Shigella sonnei]. Carević B; Bjelović M; Lepsanović Z; Jovanović M; Cobeljić M Vojnosanit Pregl; 1997; 54(6):565-70. PubMed ID: 9481933 [TBL] [Abstract][Full Text] [Related]
28. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Akasaka T; Tanaka M; Yamaguchi A; Sato K Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683 [TBL] [Abstract][Full Text] [Related]
29. Drug resistance of Shigella strains isolated in Ankara, Turkey, 1993-1996. Aysev AD; Guriz H Scand J Infect Dis; 1998; 30(4):351-3. PubMed ID: 9817513 [TBL] [Abstract][Full Text] [Related]
30. [Typing of Shigella sonnei strains isolated in some provinces of Turkey using antimicrobial resistance and pulsed field gel electrophoresis methods]. Akçali A; Levent B; Akbaş E; Esen B Mikrobiyol Bul; 2008 Oct; 42(4):563-72. PubMed ID: 19149077 [TBL] [Abstract][Full Text] [Related]
31. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections. Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409 [TBL] [Abstract][Full Text] [Related]
32. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae. Broskey J; Coleman K; Gwynn MN; McCloskey L; Traini C; Voelker L; Warren R J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():95-9. PubMed ID: 10824039 [TBL] [Abstract][Full Text] [Related]
33. [Antibiotic susceptibility patterns among Shigella sonnei, isolated during three different periods in Región Metropolitana, Chile]. Marcoleta A; Toro C; Prado V; Serrano M; Fernández P; Benadof D; Camponovo R; Campos V; Porte L; Zamorano J; Ortega C; Urqueta B; Ulloa MT Rev Chilena Infectol; 2013 Dec; 30(6):616-21. PubMed ID: 24522304 [TBL] [Abstract][Full Text] [Related]
34. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro. Gootz TD; Zaniewski R; Haskell S; Schmieder B; Tankovic J; Girard D; Courvalin P; Polzer RJ Antimicrob Agents Chemother; 1996 Dec; 40(12):2691-7. PubMed ID: 9124824 [TBL] [Abstract][Full Text] [Related]
35. [Sensitivity of Shigella to antibiotics]. Garanin BA Antibiot Khimioter; 1992 Feb; 37(2):19-20. PubMed ID: 1514848 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis. Nakanishi N; Yoshida S; Wakebe H; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1991 Jun; 35(6):1053-9. PubMed ID: 1656852 [TBL] [Abstract][Full Text] [Related]